NCT06268262

Brief Summary

The global obesity epidemic is well established, and is an important public health issue. The previous researches had applied the clues that obesity is a kind of systemic disease. The investigators hypothesized that a serious alteration of the body systems will occur after bariatric surgery, which may shed light on the mechanisms of obesity. Thus, the research aims to combine the imaging and surgery to investigate the alterations of the body that induced by obese and alterations after surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
31mo left

Started Mar 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Mar 2023Dec 2028

Study Start

First participant enrolled

March 1, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 20, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

3.8 years

First QC Date

February 6, 2024

Last Update Submit

March 13, 2024

Conditions

Keywords

ObesityOverweightMRIBariatric surgeryFatty liver

Outcome Measures

Primary Outcomes (3)

  • Imaging parameters of obesity

    Brain cortical thickness in millimeter

    baseline, 6th month

  • Imaging parameters of obesity

    The volume of left ventricle in cubic millimeter

    baseline, 6th month

  • Imaging parameters of obesity

    Fat fraction of liver (dividing the in-phase fat attenuation signal by the out-phase fat attenuation signal)

    baseline, 6th month

Secondary Outcomes (4)

  • Neurotransmitter, inflammatory factors and hormones related to obesity in blood sample

    baseline, 6th month

  • Neurotransmitter, inflammatory factors and hormones relating to obesity in blood sample

    baseline, 6th month

  • Neurotransmitter, inflammatory factors and hormones related to obesity in blood sample

    baseline, 6th month

  • Genetic information from venous blood sample, biopsied liver tissue, biopsied fat tissue, and gastric tissue

    baseline

Study Arms (2)

Obesity

Non-intervention

Healthy control

Non-intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Aged between 18 and 65, regardless of gender. Initially diagnosed as obesity (BMI\>28) and plan to undergo bariatric surgery.

You may qualify if:

  • Meeting the obesity criteria (BMI \> 28); 2) Meeting the indications for bariatric surgery, planning to undergo surgery for the first time; 3) Age between 18-65 years old, no gender restrictions; 4) Right-handed, of Han ethnicity; 5) Informed consent to the study, willing to cooperate with the research, and able to sign an informed consent form.
  • Healthy volunteers with a BMI between 18.5-23.9;
  • Age between 18-65 years old, no gender restrictions;
  • Right-handed, of Han ethnicity;
  • Informed consent to the study, willing to cooperate with the research, and able to sign an informed consent form.

You may not qualify if:

  • Secondary obesity caused by other organic diseases or medication (such as hormone use, etc.);
  • Unable to undergo surgery as planned;
  • Pregnant or breastfeeding;
  • Low cognitive ability and incapable of cooperating with the study;
  • Eating disorders;
  • Alcohol or drug dependence;
  • Meeting the criteria for organic mental disorders, severe mental disorders (schizophrenia, etc.), or other serious mental illnesses requiring clinical intervention;
  • Contraindications for MR scanning (pacemakers, cochlear implants, metal objects in the body, claustrophobia, weight exceeding the machine's load limit, etc.);
  • History of neurological organic diseases (brain tumors, epilepsy, cerebrovascular accidents, severe head trauma, etc.);
  • History of congenital heart disease (myocardial infarction, severe arrhythmias, heart failure, cardiomyopathy, rheumatic heart disease, congenital heart disease, etc.);
  • Severe liver, kidney, lung, digestive dysfunction, endocrine, and blood system diseases;
  • Active infections within the last two weeks (fever, upper respiratory infection, acute gastroenteritis, etc.);
  • Use of drugs affecting the nervous system or psychotropic drugs within the last six months.
  • The same criteria as points 3) to 13) above.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, 221000, China

RECRUITING

Related Publications (5)

  • Tutor AW, Lavie CJ, Kachur S, Milani RV, Ventura HO. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2023 May-Jun;78:2-10. doi: 10.1016/j.pcad.2022.11.013. Epub 2022 Dec 5.

    PMID: 36481212BACKGROUND
  • Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes. 2019 Feb;20(1):5-9. doi: 10.1111/pedi.12787. Epub 2018 Nov 5.

    PMID: 30311716BACKGROUND
  • Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000 Apr 6;404(6778):661-71. doi: 10.1038/35007534.

    PMID: 10766253BACKGROUND
  • Raji CA, Meysami S, Hashemi S, Garg S, Akbari N, Gouda A, Chodakiewitz YG, Nguyen TD, Niotis K, Merrill DA, Attariwala R. Visceral and Subcutaneous Abdominal Fat Predict Brain Volume Loss at Midlife in 10,001 Individuals. Aging Dis. 2024 Aug 1;15(4):1831-1842. doi: 10.14336/AD.2023.0820.

    PMID: 37728587BACKGROUND
  • Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. Int J Mol Sci. 2021 Oct 27;22(21):11629. doi: 10.3390/ijms222111629.

    PMID: 34769060BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Venous blood samples, biopsied liver tissue, biopsied fat tissue, gastric tissue

MeSH Terms

Conditions

OverweightObesityFatty Liver

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsLiver DiseasesDigestive System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 20, 2024

Study Start

March 1, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2028

Last Updated

March 15, 2024

Record last verified: 2024-03

Locations